We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

63 hedge funds and large institutions have $164M invested in iShares US Pharmaceuticals ETF in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

107.64% more ownership

Funds ownership: 0% → 107.64% (+108%)

Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$28.4M +$28.4M +853,854 New
Bank of America
2
Bank of America
North Carolina
$23.1M +$23.1M +694,062 New
Wells Fargo
3
Wells Fargo
California
$11.8M +$11.8M +355,170 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$9.83M +$9.84M +296,067 New
BCI
5
Brinker Capital Investments
Pennsylvania
$9.41M +$9.41M +283,200 New
Brown Advisory
6
Brown Advisory
Maryland
$7.18M +$7.18M +216,144 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$7M +$7M +210,774 New
SFI
8
SPC Financial Inc
Maryland
$6.26M +$6.26M +188,475 New
CCMG
9
Clark Capital Management Group
Pennsylvania
$6.13M +$6.13M +184,641 New
Rafferty Asset Management
10
Rafferty Asset Management
New York
$5.77M +$5.77M +173,700 New
MCM
11
Murphy Capital Management
New Jersey
$4.55M +$4.55M +136,920 New
PAMU
12
Pictet Asset Management (UK)
United Kingdom
$4.3M +$4.31M +129,570 New
ST
13
Spinnaker Trust
Maine
$3.93M +$3.93M +118,269 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$3.73M +$3.73M +112,248 New
U
15
UBS
Switzerland
$3.26M +$3.26M +98,112 New
LPL Financial
16
LPL Financial
California
$3.25M +$3.25M +97,758 New
RJA
17
Raymond James & Associates
Florida
$3.03M +$3.03M +91,116 New
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
$2.62M +$2.62M +78,777 New
EC
19
Estate Counselors
Wisconsin
$1.91M +$1.89M +57,015 New
SWM
20
Strategic Wealth Management
Washington
$1.79M +$1.79M +53,775 New
PAG
21
Pinnacle Advisory Group
Maryland
$1.76M +$1.76M +52,950 New
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$1.76M +$1.76M +52,929 New
RJFSA
23
Raymond James Financial Services Advisors
Florida
$1.41M +$1.41M +42,513 New
PP
24
Patten & Patten
Tennessee
$1.22M +$1.22M +36,750 New
DADC
25
D.A. Davidson & Co
Montana
$1.19M +$1.19M +35,718 New
1
2 3

IHE Hedge Fund Activity: Q2 2013 in Review

63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q2 2013, worth a combined $164M.

Buyers outnumbered sellers: 63 funds opened new IHE positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $164M of iShares US Pharmaceuticals ETF stock for Q2 2013.
  • 63 funds opened new iShares US Pharmaceuticals ETF positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.